Biomarker Study for Personalized Anti-cancer Therapy in Gastrointestinal Cancer
Not Applicable
- Conditions
- Esophageal Cancer, Gastric Cancer, Colorectal Cancer, Pancreatic Cancer, Biliary Tract Cancer,
- Registration Number
- JPRN-UMIN000004069
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Kyoto University Hospital
- Brief Summary
This research has been included into the projects in the Kyoto University Clinical Bio-resource Center.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Chemoradiation except for esophageal cancer treatment 2) Active infectious disease 3) Ileus 4) Severe diarrhea 5) Interstitial pneumonia 6) Severe diabetes 7) Under treatment for unstable angina or myocardial infarction 8) Metastasis to central nervus system 9) Massive ascites or pleural effusion 10) Dementia 11) Other inappropriate cases according to primary doctor's evaluation
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identification and clinical application of predictors of tumor response and adverse events in GI cancer chemotherapy
- Secondary Outcome Measures
Name Time Method